Cysview Kit
Product Images NDC 10511-3001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Cysview (NDC 10511-3001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Photocure Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Cysview 01)

FDA Label Image

Figure 1a (Cysview 02)

FDA Label Image

Figure 2 (Cysview 03)

FDA Label Image

Figure 3 (Cysview 04)

FDA Label Image

Figure 4 (Cysview 05)

FDA Label Image

Figure 5 (Cysview 06)

FDA Label Image

Figure 6 (Cysview 07)

FDA Label Image

Figure 7 (Cysview 08)

FDA Label Image

Figure 8 (Cysview 09)

FDA Label Image

Figure 9 (Cysview 10)

FDA Label Image

Figure 10 (Cysview 11)

FDA Label Image

Figure 11 (Cysview 12)

FDA Label Image

Chemical Structure (Cysview 13)

FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
CYSVIEW is a kit for intravesical solution containing hexaminolevulinate HCI, which is meant for bladder instillation only after reconstitution. The suggested dosage and administration include reconstitution of CYSVIEW along with the provided diluent and using it shortly after reconstitution for bladder instillation only. The reconstituted solution is required to be refrigerated at 2°-8°C if not utilized immediately and should be used within 2 hours of preparation. However, based on the given text, it is not possible to understand the purpose of the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.